Loxo Oncology
1 Landmark Square
Suite 1122
Stamford
Connecticut
06901
United States
Tel: 203-653-3880
Website: http://www.loxooncology.com/
Email: info@loxooncology.com
109 articles about Loxo Oncology
-
This Drug Discovery Company Just Struck a $40 Million Deal with Loxo Oncology
7/31/2017
-
Loxo Oncology Announces The Closing Of Its Follow-On Offering Of Common Stock And Full Exercise Of The Underwriters’ Option To Purchase Additional Shares
6/21/2017
-
Loxo Oncology Prices Follow-On Offering Of Common Stock
6/15/2017
-
Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It
6/8/2017
-
Loxo Oncology Announces Clinical Proof Of Concept Publication For Next-Generation TRK Inhibitor LOXO-195
6/5/2017
-
Loxo Oncology Announces FDA Clearance Of Investigational New Drug (IND) Application For Next-Generation TRK Inhibitor, LOXO-195
5/30/2017
-
Loxo Oncology Announces Details of Two Larotrectinib Clinical Data Oral Presentations at the 2017 ASCO Annual Meeting
5/18/2017
-
Loxo Oncology Announces FDA Orphan Drug Designation Granted To Larotrectinib For The Treatment Of Solid Tumors With NTRK-Fusion Proteins
5/12/2017
-
Loxo Oncology Announces Enrollment Of First Patient In Phase I Clinical Trial For Highly Selective RET Inhibitor, LOXO-292
5/10/2017
-
Loxo Oncology Announces First Quarter 2017 Financial Results
5/9/2017
-
Loxo Oncology To Announce First Quarter 2017 Financial Results
5/2/2017
-
Loxo Oncology TRK Inhibitor LOXO-101 Shows Durable Anti-Tumor Activity Across TRK Fusion Cancers In AACR Phase 1 Update
4/18/2016
-
Loxo Oncology Prices Follow-On Offering Of Common Stock
11/12/2015
-
Loxo Oncology Announces Proposed Public Offering Of Common Stock
11/11/2015
-
Loxo Oncology To Present At Upcoming Investor Conferences
11/10/2015
-
Loxo Oncology Announces Third Quarter 2015 Financial Results And Provides Program Updates
11/10/2015
-
Loxo Oncology TRK Inhibitor LOXO-101 Demonstrates Promising Clinical Activity And Safety In Phase 1 Trial
11/9/2015
-
Loxo Oncology Announces Transition Of Chief Medical Officer
11/5/2015
-
Loxo Oncology To Announce Third Quarter 2015 Financial Results
11/3/2015
-
Loxo Oncology Announces Broad Pipeline Update At AACR-National Cancer Institute-EORTC, Including New LOXO-101 Phase 1 Data
10/26/2015